top of page
icononly_transparent_nobuffer.png

Oncology CoPilot

The Oncology CoPilot Platform equips oncologists, diagnostic laboratories and research organizations with cutting-edge AI-powered drug-cancer biological network analysis software. It delves deep into the intricate tumor biology of every cancer patient, facilitating well-informed treatment decisions. By analyzing high-throughput gene expression profiling data, the platform conducts thorough evaluations of tumors, encompassing molecular subtyping, microenvironment, and immune response assessments. It then generates personalized therapy options, ranked by the probability of drug response. This empowers oncologists to craft precise and effective treatment plans tailored to each individual patient, across all cancer types, with access to over 240 drug options.

Artboard 1 copy 7_edited_edited.png
Clinician-Assistance Platform

Streamlining cancer treatment decisions by analyzing complex tumor gene expression data  to identify the most effective drugs.

Artboard 1_edited.png
Treatment Decision Support

Generates a report with a ranked list of drug options by probability of success. Empowers clinicians to make informed and effective decisions.

Artboard 1 copy_edited.png
Benefits & Outcomes

Reduce costs and save time from reviewing complex gene expression data. This leads to increased revenue and improved patient outcomes.

Process

online account_edited.jpg

Log into your account

Secure, HIPAA compliant server

Upload patient and cancer data for analysis

Data is encrypted in transit and at rest

AI model that improve with more data

genetic information_edited_edited.jpg
analysis report without a person or anim

View report to determine the best cancer treatments for each unique patient

Tumor analysis

Drug response prediction

bottom of page